Vanguard Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-311,761
Closed -$16.5M 4239
2020
Q3
$16.5M Sell
311,761
-331
-0.1% -$17.5K ﹤0.01% 2549
2020
Q2
$19.1M Buy
312,092
+25,532
+9% +$1.56M ﹤0.01% 2451
2020
Q1
$16.2M Buy
286,560
+1,397
+0.5% +$79K ﹤0.01% 2384
2019
Q4
$16.2M Sell
285,163
-1,081
-0.4% -$61.6K ﹤0.01% 2629
2019
Q3
$15.3M Buy
286,244
+9,011
+3% +$482K ﹤0.01% 2600
2019
Q2
$16.6M Buy
277,233
+1,320
+0.5% +$78.8K ﹤0.01% 2606
2019
Q1
$17.2M Buy
275,913
+6,014
+2% +$375K ﹤0.01% 2574
2018
Q4
$16.4M Buy
269,899
+6,799
+3% +$412K ﹤0.01% 2529
2018
Q3
$15.4M Buy
263,100
+3,433
+1% +$201K ﹤0.01% 2705
2018
Q2
$11.6M Buy
259,667
+7,897
+3% +$354K ﹤0.01% 2826
2018
Q1
$11.2M Buy
251,770
+16,975
+7% +$753K ﹤0.01% 2785
2017
Q4
$10.2M Buy
234,795
+14,933
+7% +$647K ﹤0.01% 2809
2017
Q3
$10.2M Buy
219,862
+19,408
+10% +$903K ﹤0.01% 2795
2017
Q2
$9.92M Buy
200,454
+3,030
+2% +$150K ﹤0.01% 2773
2017
Q1
$10.8M Buy
197,424
+1,879
+1% +$103K ﹤0.01% 2727
2016
Q4
$10.9M Sell
195,545
-4,362
-2% -$243K ﹤0.01% 2710
2016
Q3
$9.13M Buy
199,907
+2,130
+1% +$97.3K ﹤0.01% 2734
2016
Q2
$7.9M Buy
197,777
+3,638
+2% +$145K ﹤0.01% 2757
2016
Q1
$6.76M Buy
194,139
+10,168
+6% +$354K ﹤0.01% 2808
2015
Q4
$7.91M Buy
183,971
+9,036
+5% +$388K ﹤0.01% 2765
2015
Q3
$7.62M Buy
174,935
+30,651
+21% +$1.33M ﹤0.01% 2750
2015
Q2
$7.45M Buy
144,284
+7,688
+6% +$397K ﹤0.01% 2818
2015
Q1
$5.35M Buy
136,596
+7,884
+6% +$309K ﹤0.01% 2966
2014
Q4
$4.97M Buy
128,712
+2,540
+2% +$98.1K ﹤0.01% 2905
2014
Q3
$4.45M Buy
126,172
+3,954
+3% +$140K ﹤0.01% 2896
2014
Q2
$3.3M Buy
122,218
+6,527
+6% +$176K ﹤0.01% 3039
2014
Q1
$3M Buy
115,691
+6,082
+6% +$158K ﹤0.01% 3049
2013
Q4
$2.38M Buy
109,609
+3,598
+3% +$78K ﹤0.01% 3122
2013
Q3
$2.06M Buy
106,011
+624
+0.6% +$12.1K ﹤0.01% 3119
2013
Q2
$1.64M Buy
+105,387
New +$1.64M ﹤0.01% 3137